| (210) | Number of the EPO application | 19858443 |
| (220) | Filing date of the EPO application | 2019.09.04 |
| (80) | EPO patent specification publication (B) | EPB nr. 06/2024, 2024.02.07 |
| (110) | EPO patent number | 3847175 |
| (11) | Number of the document | MD 3847175 T2 |
| (21) | Number of the application | e 2021 0648 |
| (71) | Name(s) of applicant(s), code of the country | INCYTE CORPORATION, US; |
| (72) | Name(s) of inventor(s), code of the country | DOUTY Brent, US;
BURNS David M., US;
COMBS Andrew P., US;
JIA Zhongjiang, US;
LEVY Daniel, US;
YUE Eddy W., US; |
| (73) | Name(s) of owner(s), code of the country | INCYTE CORPORATION, US; |
| (54) | Title of the invention | Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 487/04 (2006.01.01); C07D 471/02 (2006.01.01); C07D 471/04 (2006.01.01); A61K 31/395 (2006.01.01); A61K 31/435 (2006.01.01); A61K 31/4353 (2006.01.01); A61K 31/437 (2006.01.01); A61K 31/495 (2006.01.01); A61K 31/4985 (2006.01.01); A61P 25/28 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2024.08.31 |
| (30) | Priority | 201862727321 P, 2018.09.05, US; 201862727328 P, 2018.09.05, US; 201862727339 P, 2018.09.05, US; 201862746928 P, 2018.10.17, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2019/049419, 2019.09.04 |
| (87) | International publication | WO 2020/051169, 2020.03.12 |